Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bronchiolitis Obliterans Syndrome × RO6839921 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 2 Leukemia, Myeloid 2 Bronchiolitis Obliterans Syndrome 1

Interventions

obinutuzumab 2 ofatumumab 1 milatuzumab 1 ibrutinib 1 fenebrutinib 1 abexinostat 1 RO6839921 1 KW-2478 1 Interleukin-15 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01677780 2017-07-07

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Hoffmann-La Roche

Phase 1 Completed

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myeloid, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡